Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. SNSE Peers
See (SNSE) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNSE | $0.34 | -4.71% | 8.56M | -0.30 | -$1.15 | N/A |
| VRTX | $421.16 | -2.51% | 108.15B | -110.25 | -$3.82 | N/A |
| REGN | $571.36 | -0.49% | 60.65B | 14.53 | $39.32 | +0.15% |
| SGEN | $228.74 | -0.07% | 43.15B | -57.19 | -$4.00 | N/A |
| ALNY | $267.55 | +0.26% | 34.89B | -126.80 | -$2.11 | N/A |
| ARGX | $532.27 | -1.88% | 32.50B | 32.50 | $16.38 | N/A |
| BNTX | $92.09 | -2.56% | 22.14B | -25.65 | -$3.59 | N/A |
| BGNE | $184.71 | +0.49% | 20.21B | -22.55 | -$8.19 | N/A |
| DNA-WT | $0.27 | -2.76% | 18.73B | N/A | N/A | N/A |
| RPRX | $32.29 | -1.61% | 18.16B | 13.18 | $2.45 | +2.63% |
Stock Comparison
SNSE vs VRTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, VRTX has a market cap of 108.15B. Regarding current trading prices, SNSE is priced at $0.34, while VRTX trades at $421.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas VRTX's P/E ratio is -110.25. In terms of profitability, SNSE's ROE is -0.69%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, SNSE is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs REGN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, REGN has a market cap of 60.65B. Regarding current trading prices, SNSE is priced at $0.34, while REGN trades at $571.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas REGN's P/E ratio is 14.53. In terms of profitability, SNSE's ROE is -0.69%, compared to REGN's ROE of +0.15%. Regarding short-term risk, SNSE is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs SGEN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, SGEN has a market cap of 43.15B. Regarding current trading prices, SNSE is priced at $0.34, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas SGEN's P/E ratio is -57.19. In terms of profitability, SNSE's ROE is -0.69%, compared to SGEN's ROE of -0.17%. Regarding short-term risk, SNSE is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ALNY Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ALNY has a market cap of 34.89B. Regarding current trading prices, SNSE is priced at $0.34, while ALNY trades at $267.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ALNY's P/E ratio is -126.80. In terms of profitability, SNSE's ROE is -0.69%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, SNSE is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ARGX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ARGX has a market cap of 32.50B. Regarding current trading prices, SNSE is priced at $0.34, while ARGX trades at $532.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ARGX's P/E ratio is 32.50. In terms of profitability, SNSE's ROE is -0.69%, compared to ARGX's ROE of +0.16%. Regarding short-term risk, SNSE is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs BNTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BNTX has a market cap of 22.14B. Regarding current trading prices, SNSE is priced at $0.34, while BNTX trades at $92.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BNTX's P/E ratio is -25.65. In terms of profitability, SNSE's ROE is -0.69%, compared to BNTX's ROE of -0.03%. Regarding short-term risk, SNSE is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs BGNE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BGNE has a market cap of 20.21B. Regarding current trading prices, SNSE is priced at $0.34, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BGNE's P/E ratio is -22.55. In terms of profitability, SNSE's ROE is -0.69%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, SNSE is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs DNA-WT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, DNA-WT has a market cap of 18.73B. Regarding current trading prices, SNSE is priced at $0.34, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, SNSE's ROE is -0.69%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, SNSE is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs RPRX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RPRX has a market cap of 18.16B. Regarding current trading prices, SNSE is priced at $0.34, while RPRX trades at $32.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RPRX's P/E ratio is 13.18. In terms of profitability, SNSE's ROE is -0.69%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, SNSE is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs SMMT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, SMMT has a market cap of 16.78B. Regarding current trading prices, SNSE is priced at $0.34, while SMMT trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas SMMT's P/E ratio is -66.91. In terms of profitability, SNSE's ROE is -0.69%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, SNSE is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs UTHR Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, UTHR has a market cap of 13.52B. Regarding current trading prices, SNSE is priced at $0.34, while UTHR trades at $299.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas UTHR's P/E ratio is 11.93. In terms of profitability, SNSE's ROE is -0.69%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, SNSE is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs KRTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, KRTX has a market cap of 12.60B. Regarding current trading prices, SNSE is priced at $0.34, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas KRTX's P/E ratio is -28.09. In terms of profitability, SNSE's ROE is -0.69%, compared to KRTX's ROE of -0.25%. Regarding short-term risk, SNSE is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs EXEL Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, EXEL has a market cap of 12.30B. Regarding current trading prices, SNSE is priced at $0.34, while EXEL trades at $44.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas EXEL's P/E ratio is 25.37. In terms of profitability, SNSE's ROE is -0.69%, compared to EXEL's ROE of +0.24%. Regarding short-term risk, SNSE is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs GMAB Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, GMAB has a market cap of 11.86B. Regarding current trading prices, SNSE is priced at $0.34, while GMAB trades at $19.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas GMAB's P/E ratio is 11.16. In terms of profitability, SNSE's ROE is -0.69%, compared to GMAB's ROE of +0.24%. Regarding short-term risk, SNSE is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs INCY Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, INCY has a market cap of 11.84B. Regarding current trading prices, SNSE is priced at $0.34, while INCY trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas INCY's P/E ratio is 305.80. In terms of profitability, SNSE's ROE is -0.69%, compared to INCY's ROE of +0.01%. Regarding short-term risk, SNSE is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs BMRN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BMRN has a market cap of 11.26B. Regarding current trading prices, SNSE is priced at $0.34, while BMRN trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BMRN's P/E ratio is 21.74. In terms of profitability, SNSE's ROE is -0.69%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, SNSE is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs RXDX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RXDX has a market cap of 9.56B. Regarding current trading prices, SNSE is priced at $0.34, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RXDX's P/E ratio is -56.47. In terms of profitability, SNSE's ROE is -0.69%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, SNSE is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ASND Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ASND has a market cap of 9.49B. Regarding current trading prices, SNSE is priced at $0.34, while ASND trades at $157.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ASND's P/E ratio is -24.07. In terms of profitability, SNSE's ROE is -0.69%, compared to ASND's ROE of +1.91%. Regarding short-term risk, SNSE is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MRNA Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MRNA has a market cap of 9.29B. Regarding current trading prices, SNSE is priced at $0.34, while MRNA trades at $24.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MRNA's P/E ratio is -2.75. In terms of profitability, SNSE's ROE is -0.69%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, SNSE is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs IMGN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, IMGN has a market cap of 8.73B. Regarding current trading prices, SNSE is priced at $0.34, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas IMGN's P/E ratio is -111.55. In terms of profitability, SNSE's ROE is -0.69%, compared to IMGN's ROE of +0.05%. Regarding short-term risk, SNSE is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs CERE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CERE has a market cap of 8.19B. Regarding current trading prices, SNSE is priced at $0.34, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CERE's P/E ratio is -16.47. In terms of profitability, SNSE's ROE is -0.69%, compared to CERE's ROE of -0.99%. Regarding short-term risk, SNSE is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ROIVW Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ROIVW has a market cap of 7.83B. Regarding current trading prices, SNSE is priced at $0.34, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, SNSE's ROE is -0.69%, compared to ROIVW's ROE of -0.02%. Regarding short-term risk, SNSE is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs ROIV Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ROIV has a market cap of 7.61B. Regarding current trading prices, SNSE is priced at $0.34, while ROIV trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ROIV's P/E ratio is -10.67. In terms of profitability, SNSE's ROE is -0.69%, compared to ROIV's ROE of -0.02%. Regarding short-term risk, SNSE is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs CORT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CORT has a market cap of 7.51B. Regarding current trading prices, SNSE is priced at $0.34, while CORT trades at $70.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CORT's P/E ratio is 61.58. In terms of profitability, SNSE's ROE is -0.69%, compared to CORT's ROE of +0.20%. Regarding short-term risk, SNSE is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs TECH Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, TECH has a market cap of 7.50B. Regarding current trading prices, SNSE is priced at $0.34, while TECH trades at $47.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas TECH's P/E ratio is 57.66. In terms of profitability, SNSE's ROE is -0.69%, compared to TECH's ROE of +0.06%. Regarding short-term risk, SNSE is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs RVMD Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RVMD has a market cap of 7.35B. Regarding current trading prices, SNSE is priced at $0.34, while RVMD trades at $39.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RVMD's P/E ratio is -9.85. In terms of profitability, SNSE's ROE is -0.69%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, SNSE is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs JAZZ Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, JAZZ has a market cap of 6.57B. Regarding current trading prices, SNSE is priced at $0.34, while JAZZ trades at $106.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas JAZZ's P/E ratio is 14.48. In terms of profitability, SNSE's ROE is -0.69%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, SNSE is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs RETA Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RETA has a market cap of 6.57B. Regarding current trading prices, SNSE is priced at $0.34, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RETA's P/E ratio is -66.29. In terms of profitability, SNSE's ROE is -0.69%, compared to RETA's ROE of +0.47%. Regarding short-term risk, SNSE is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs BBIO Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BBIO has a market cap of 6.39B. Regarding current trading prices, SNSE is priced at $0.34, while BBIO trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BBIO's P/E ratio is -9.46. In terms of profitability, SNSE's ROE is -0.69%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, SNSE is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs BPMC Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BPMC has a market cap of 6.30B. Regarding current trading prices, SNSE is priced at $0.34, while BPMC trades at $97.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BPMC's P/E ratio is -38.85. In terms of profitability, SNSE's ROE is -0.69%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, SNSE is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MDGL Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MDGL has a market cap of 6.28B. Regarding current trading prices, SNSE is priced at $0.34, while MDGL trades at $282.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MDGL's P/E ratio is -15.86. In terms of profitability, SNSE's ROE is -0.69%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, SNSE is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs HALO Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, HALO has a market cap of 5.90B. Regarding current trading prices, SNSE is priced at $0.34, while HALO trades at $47.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas HALO's P/E ratio is 12.74. In terms of profitability, SNSE's ROE is -0.69%, compared to HALO's ROE of +1.22%. Regarding short-term risk, SNSE is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs VRNA Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, VRNA has a market cap of 5.71B. Regarding current trading prices, SNSE is priced at $0.34, while VRNA trades at $67.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas VRNA's P/E ratio is -33.62. In terms of profitability, SNSE's ROE is -0.69%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, SNSE is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ABCM Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ABCM has a market cap of 5.52B. Regarding current trading prices, SNSE is priced at $0.34, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, SNSE's ROE is -0.69%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, SNSE is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ISEE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ISEE has a market cap of 5.51B. Regarding current trading prices, SNSE is priced at $0.34, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ISEE's P/E ratio is -22.44. In terms of profitability, SNSE's ROE is -0.69%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, SNSE is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs TLX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, TLX has a market cap of 5.49B. Regarding current trading prices, SNSE is priced at $0.34, while TLX trades at $16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas TLX's P/E ratio is 182.22. In terms of profitability, SNSE's ROE is -0.69%, compared to TLX's ROE of +0.14%. Regarding short-term risk, SNSE is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs TGTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, TGTX has a market cap of 5.30B. Regarding current trading prices, SNSE is priced at $0.34, while TGTX trades at $33.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas TGTX's P/E ratio is 133.60. In terms of profitability, SNSE's ROE is -0.69%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, SNSE is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs IONS Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, IONS has a market cap of 5.19B. Regarding current trading prices, SNSE is priced at $0.34, while IONS trades at $32.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas IONS's P/E ratio is -10.90. In terms of profitability, SNSE's ROE is -0.69%, compared to IONS's ROE of -0.00%. Regarding short-term risk, SNSE is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs AXSM Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, AXSM has a market cap of 5.10B. Regarding current trading prices, SNSE is priced at $0.34, while AXSM trades at $103.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas AXSM's P/E ratio is -17.97. In terms of profitability, SNSE's ROE is -0.69%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, SNSE is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs NUVL Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, NUVL has a market cap of 5.10B. Regarding current trading prices, SNSE is priced at $0.34, while NUVL trades at $71.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas NUVL's P/E ratio is -16.07. In terms of profitability, SNSE's ROE is -0.69%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, SNSE is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ALKS Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ALKS has a market cap of 5.05B. Regarding current trading prices, SNSE is priced at $0.34, while ALKS trades at $30.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ALKS's P/E ratio is 14.58. In terms of profitability, SNSE's ROE is -0.69%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, SNSE is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ADMA Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ADMA has a market cap of 4.65B. Regarding current trading prices, SNSE is priced at $0.34, while ADMA trades at $19.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ADMA's P/E ratio is 23.18. In terms of profitability, SNSE's ROE is -0.69%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, SNSE is more volatile compared to ADMA. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ALPN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ALPN has a market cap of 4.46B. Regarding current trading prices, SNSE is priced at $0.34, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ALPN's P/E ratio is -101.52. In terms of profitability, SNSE's ROE is -0.69%, compared to ALPN's ROE of -0.15%. Regarding short-term risk, SNSE is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs OPT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, OPT has a market cap of 4.20B. Regarding current trading prices, SNSE is priced at $0.34, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas OPT's P/E ratio is -1.52. In terms of profitability, SNSE's ROE is -0.69%, compared to OPT's ROE of +2.60%. Regarding short-term risk, SNSE is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MRTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MRTX has a market cap of 4.12B. Regarding current trading prices, SNSE is priced at $0.34, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MRTX's P/E ratio is -4.82. In terms of profitability, SNSE's ROE is -0.69%, compared to MRTX's ROE of -0.40%. Regarding short-term risk, SNSE is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs KRYS Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, KRYS has a market cap of 3.80B. Regarding current trading prices, SNSE is priced at $0.34, while KRYS trades at $131.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas KRYS's P/E ratio is 31.51. In terms of profitability, SNSE's ROE is -0.69%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, SNSE is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs PCVX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, PCVX has a market cap of 3.80B. Regarding current trading prices, SNSE is priced at $0.34, while PCVX trades at $29.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas PCVX's P/E ratio is -7.37. In terms of profitability, SNSE's ROE is -0.69%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, SNSE is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs RYZB Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RYZB has a market cap of 3.75B. Regarding current trading prices, SNSE is priced at $0.34, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RYZB's P/E ratio is -57.86. In terms of profitability, SNSE's ROE is -0.69%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, SNSE is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs CBAY Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CBAY has a market cap of 3.73B. Regarding current trading prices, SNSE is priced at $0.34, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CBAY's P/E ratio is -32.81. In terms of profitability, SNSE's ROE is -0.69%, compared to CBAY's ROE of -0.32%. Regarding short-term risk, SNSE is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs PTCT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, PTCT has a market cap of 3.71B. Regarding current trading prices, SNSE is priced at $0.34, while PTCT trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas PTCT's P/E ratio is 7.18. In terms of profitability, SNSE's ROE is -0.69%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, SNSE is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs RYTM Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RYTM has a market cap of 3.64B. Regarding current trading prices, SNSE is priced at $0.34, while RYTM trades at $57.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RYTM's P/E ratio is -20.46. In terms of profitability, SNSE's ROE is -0.69%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, SNSE is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs CYTK Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CYTK has a market cap of 3.58B. Regarding current trading prices, SNSE is priced at $0.34, while CYTK trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CYTK's P/E ratio is -5.67. In terms of profitability, SNSE's ROE is -0.69%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, SNSE is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs SRPT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, SRPT has a market cap of 3.51B. Regarding current trading prices, SNSE is priced at $0.34, while SRPT trades at $35.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas SRPT's P/E ratio is -13.54. In terms of profitability, SNSE's ROE is -0.69%, compared to SRPT's ROE of -0.20%. Regarding short-term risk, SNSE is more volatile compared to SRPT. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs SWTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, SWTX has a market cap of 3.48B. Regarding current trading prices, SNSE is priced at $0.34, while SWTX trades at $46.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas SWTX's P/E ratio is -13.55. In terms of profitability, SNSE's ROE is -0.69%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, SNSE is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs RNA Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RNA has a market cap of 3.42B. Regarding current trading prices, SNSE is priced at $0.34, while RNA trades at $28.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RNA's P/E ratio is -9.47. In terms of profitability, SNSE's ROE is -0.69%, compared to RNA's ROE of -0.27%. Regarding short-term risk, SNSE is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs RARE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, RARE has a market cap of 3.28B. Regarding current trading prices, SNSE is priced at $0.34, while RARE trades at $34.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas RARE's P/E ratio is -5.96. In terms of profitability, SNSE's ROE is -0.69%, compared to RARE's ROE of -1.86%. Regarding short-term risk, SNSE is more volatile compared to RARE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ACLX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ACLX has a market cap of 3.25B. Regarding current trading prices, SNSE is priced at $0.34, while ACLX trades at $59.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ACLX's P/E ratio is -19.74. In terms of profitability, SNSE's ROE is -0.69%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, SNSE is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs SLNO Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, SLNO has a market cap of 3.21B. Regarding current trading prices, SNSE is priced at $0.34, while SLNO trades at $69.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas SLNO's P/E ratio is -15.97. In terms of profitability, SNSE's ROE is -0.69%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, SNSE is more volatile compared to SLNO. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs CRSP Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CRSP has a market cap of 3.07B. Regarding current trading prices, SNSE is priced at $0.34, while CRSP trades at $35.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CRSP's P/E ratio is -7.93. In terms of profitability, SNSE's ROE is -0.69%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, SNSE is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs AKRO Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, AKRO has a market cap of 3.02B. Regarding current trading prices, SNSE is priced at $0.34, while AKRO trades at $37.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas AKRO's P/E ratio is -10.10. In terms of profitability, SNSE's ROE is -0.69%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, SNSE is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs VKTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, VKTX has a market cap of 2.98B. Regarding current trading prices, SNSE is priced at $0.34, while VKTX trades at $26.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas VKTX's P/E ratio is -22.91. In terms of profitability, SNSE's ROE is -0.69%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, SNSE is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs CRNX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CRNX has a market cap of 2.93B. Regarding current trading prices, SNSE is priced at $0.34, while CRNX trades at $31.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CRNX's P/E ratio is -8.23. In terms of profitability, SNSE's ROE is -0.69%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, SNSE is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs SRRK Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, SRRK has a market cap of 2.90B. Regarding current trading prices, SNSE is priced at $0.34, while SRRK trades at $30.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas SRRK's P/E ratio is -12.36. In terms of profitability, SNSE's ROE is -0.69%, compared to SRRK's ROE of -1.29%. Regarding short-term risk, SNSE is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ACAD Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ACAD has a market cap of 2.87B. Regarding current trading prices, SNSE is priced at $0.34, while ACAD trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ACAD's P/E ratio is 12.53. In terms of profitability, SNSE's ROE is -0.69%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, SNSE is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MORF Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MORF has a market cap of 2.86B. Regarding current trading prices, SNSE is priced at $0.34, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MORF's P/E ratio is -14.88. In terms of profitability, SNSE's ROE is -0.69%, compared to MORF's ROE of -0.27%. Regarding short-term risk, SNSE is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MOR Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MOR has a market cap of 2.86B. Regarding current trading prices, SNSE is priced at $0.34, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MOR's P/E ratio is -12.64. In terms of profitability, SNSE's ROE is -0.69%, compared to MOR's ROE of +7.43%. Regarding short-term risk, SNSE is more volatile compared to MOR. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs CPRX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CPRX has a market cap of 2.85B. Regarding current trading prices, SNSE is priced at $0.34, while CPRX trades at $23.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CPRX's P/E ratio is 14.90. In terms of profitability, SNSE's ROE is -0.69%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, SNSE is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MRUS Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MRUS has a market cap of 2.80B. Regarding current trading prices, SNSE is priced at $0.34, while MRUS trades at $40.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MRUS's P/E ratio is -9.71. In terms of profitability, SNSE's ROE is -0.69%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, SNSE is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs PTGX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, PTGX has a market cap of 2.71B. Regarding current trading prices, SNSE is priced at $0.34, while PTGX trades at $43.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas PTGX's P/E ratio is 56.12. In terms of profitability, SNSE's ROE is -0.69%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, SNSE is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs KDNY Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, KDNY has a market cap of 2.71B. Regarding current trading prices, SNSE is priced at $0.34, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas KDNY's P/E ratio is -12.47. In terms of profitability, SNSE's ROE is -0.69%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, SNSE is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MYOV Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MYOV has a market cap of 2.62B. Regarding current trading prices, SNSE is priced at $0.34, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MYOV's P/E ratio is -14.05. In terms of profitability, SNSE's ROE is -0.69%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, SNSE is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MTSR Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MTSR has a market cap of 2.57B. Regarding current trading prices, SNSE is priced at $0.34, while MTSR trades at $24.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MTSR's P/E ratio is -12.06. In terms of profitability, SNSE's ROE is -0.69%, compared to MTSR's ROE of -0.55%. Regarding short-term risk, SNSE is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs LEGN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, LEGN has a market cap of 2.55B. Regarding current trading prices, SNSE is priced at $0.34, while LEGN trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas LEGN's P/E ratio is -28.96. In terms of profitability, SNSE's ROE is -0.69%, compared to LEGN's ROE of -0.16%. Regarding short-term risk, SNSE is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs PRVB Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, PRVB has a market cap of 2.38B. Regarding current trading prices, SNSE is priced at $0.34, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas PRVB's P/E ratio is -16.43. In terms of profitability, SNSE's ROE is -0.69%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, SNSE is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs APGE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, APGE has a market cap of 2.37B. Regarding current trading prices, SNSE is priced at $0.34, while APGE trades at $39.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas APGE's P/E ratio is -11.04. In terms of profitability, SNSE's ROE is -0.69%, compared to APGE's ROE of -0.19%. Regarding short-term risk, SNSE is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MLTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MLTX has a market cap of 2.35B. Regarding current trading prices, SNSE is priced at $0.34, while MLTX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MLTX's P/E ratio is -19.57. In terms of profitability, SNSE's ROE is -0.69%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, SNSE is less volatile compared to MLTX. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs LBPH Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, LBPH has a market cap of 2.34B. Regarding current trading prices, SNSE is priced at $0.34, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas LBPH's P/E ratio is -26.66. In terms of profitability, SNSE's ROE is -0.69%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, SNSE is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs IMVT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, IMVT has a market cap of 2.34B. Regarding current trading prices, SNSE is priced at $0.34, while IMVT trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas IMVT's P/E ratio is -5.26. In terms of profitability, SNSE's ROE is -0.69%, compared to IMVT's ROE of -0.78%. Regarding short-term risk, SNSE is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs XENE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, XENE has a market cap of 2.28B. Regarding current trading prices, SNSE is priced at $0.34, while XENE trades at $29.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas XENE's P/E ratio is -9.88. In terms of profitability, SNSE's ROE is -0.69%, compared to XENE's ROE of -0.32%. Regarding short-term risk, SNSE is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs DICE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, DICE has a market cap of 2.27B. Regarding current trading prices, SNSE is priced at $0.34, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas DICE's P/E ratio is -21.91. In terms of profitability, SNSE's ROE is -0.69%, compared to DICE's ROE of +0.56%. Regarding short-term risk, SNSE is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs VCYT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, VCYT has a market cap of 2.23B. Regarding current trading prices, SNSE is priced at $0.34, while VCYT trades at $28.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas VCYT's P/E ratio is 67.83. In terms of profitability, SNSE's ROE is -0.69%, compared to VCYT's ROE of +0.02%. Regarding short-term risk, SNSE is more volatile compared to VCYT. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs MIRM Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, MIRM has a market cap of 2.20B. Regarding current trading prices, SNSE is priced at $0.34, while MIRM trades at $44.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas MIRM's P/E ratio is -27.57. In terms of profitability, SNSE's ROE is -0.69%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, SNSE is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs IBRX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, IBRX has a market cap of 2.20B. Regarding current trading prices, SNSE is priced at $0.34, while IBRX trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas IBRX's P/E ratio is -4.37. In terms of profitability, SNSE's ROE is -0.69%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, SNSE is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs CALT Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, CALT has a market cap of 2.15B. Regarding current trading prices, SNSE is priced at $0.34, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas CALT's P/E ratio is -22.73. In terms of profitability, SNSE's ROE is -0.69%, compared to CALT's ROE of -2.10%. Regarding short-term risk, SNSE is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs VCEL Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, VCEL has a market cap of 2.13B. Regarding current trading prices, SNSE is priced at $0.34, while VCEL trades at $42.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas VCEL's P/E ratio is 846.00. In terms of profitability, SNSE's ROE is -0.69%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, SNSE is more volatile compared to VCEL. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs NAMS Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, NAMS has a market cap of 2.11B. Regarding current trading prices, SNSE is priced at $0.34, while NAMS trades at $18.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas NAMS's P/E ratio is -10.19. In terms of profitability, SNSE's ROE is -0.69%, compared to NAMS's ROE of -0.26%. Regarding short-term risk, SNSE is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs APLS Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, APLS has a market cap of 2.10B. Regarding current trading prices, SNSE is priced at $0.34, while APLS trades at $16.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas APLS's P/E ratio is -9.28. In terms of profitability, SNSE's ROE is -0.69%, compared to APLS's ROE of -1.00%. Regarding short-term risk, SNSE is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs ARWR Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, ARWR has a market cap of 2.06B. Regarding current trading prices, SNSE is priced at $0.34, while ARWR trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas ARWR's P/E ratio is -2.90. In terms of profitability, SNSE's ROE is -0.69%, compared to ARWR's ROE of -0.46%. Regarding short-term risk, SNSE is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs BCRX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BCRX has a market cap of 2.05B. Regarding current trading prices, SNSE is priced at $0.34, while BCRX trades at $9.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BCRX's P/E ratio is -37.75. In terms of profitability, SNSE's ROE is -0.69%, compared to BCRX's ROE of +0.15%. Regarding short-term risk, SNSE is more volatile compared to BCRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs AAPG Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, AAPG has a market cap of 2.03B. Regarding current trading prices, SNSE is priced at $0.34, while AAPG trades at $23.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas AAPG's P/E ratio is -31.69. In terms of profitability, SNSE's ROE is -0.69%, compared to AAPG's ROE of N/A. Regarding short-term risk, SNSE is more volatile compared to AAPG. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs DNLI Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, DNLI has a market cap of 2.03B. Regarding current trading prices, SNSE is priced at $0.34, while DNLI trades at $13.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas DNLI's P/E ratio is -5.23. In terms of profitability, SNSE's ROE is -0.69%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, SNSE is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs LGND Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, LGND has a market cap of 2.03B. Regarding current trading prices, SNSE is priced at $0.34, while LGND trades at $105.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas LGND's P/E ratio is -14.42. In terms of profitability, SNSE's ROE is -0.69%, compared to LGND's ROE of -0.16%. Regarding short-term risk, SNSE is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs BHVN Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BHVN has a market cap of 2.01B. Regarding current trading prices, SNSE is priced at $0.34, while BHVN trades at $19.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BHVN's P/E ratio is -2.13. In terms of profitability, SNSE's ROE is -0.69%, compared to BHVN's ROE of -2.57%. Regarding short-term risk, SNSE is less volatile compared to BHVN. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs BLTE Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BLTE has a market cap of 1.96B. Regarding current trading prices, SNSE is priced at $0.34, while BLTE trades at $61.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BLTE's P/E ratio is -52.20. In terms of profitability, SNSE's ROE is -0.69%, compared to BLTE's ROE of -0.31%. Regarding short-term risk, SNSE is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs KYMR Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, KYMR has a market cap of 1.94B. Regarding current trading prices, SNSE is priced at $0.34, while KYMR trades at $29.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas KYMR's P/E ratio is -9.57. In terms of profitability, SNSE's ROE is -0.69%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, SNSE is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs HRMY Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, HRMY has a market cap of 1.92B. Regarding current trading prices, SNSE is priced at $0.34, while HRMY trades at $33.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas HRMY's P/E ratio is 12.74. In terms of profitability, SNSE's ROE is -0.69%, compared to HRMY's ROE of +0.24%. Regarding short-term risk, SNSE is more volatile compared to HRMY. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs NAMSW Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, NAMSW has a market cap of 1.90B. Regarding current trading prices, SNSE is priced at $0.34, while NAMSW trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas NAMSW's P/E ratio is N/A. In terms of profitability, SNSE's ROE is -0.69%, compared to NAMSW's ROE of -0.26%. Regarding short-term risk, SNSE is less volatile compared to NAMSW. This indicates potentially lower risk in terms of short-term price fluctuations for SNSE.
SNSE vs TVTX Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, TVTX has a market cap of 1.87B. Regarding current trading prices, SNSE is priced at $0.34, while TVTX trades at $21.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas TVTX's P/E ratio is -7.59. In terms of profitability, SNSE's ROE is -0.69%, compared to TVTX's ROE of -11.84%. Regarding short-term risk, SNSE is more volatile compared to TVTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.
SNSE vs BLU Comparison
SNSE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNSE stands at 8.56M. In comparison, BLU has a market cap of 1.87B. Regarding current trading prices, SNSE is priced at $0.34, while BLU trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNSE currently has a P/E ratio of -0.30, whereas BLU's P/E ratio is -20.20. In terms of profitability, SNSE's ROE is -0.69%, compared to BLU's ROE of -0.06%. Regarding short-term risk, SNSE is more volatile compared to BLU. This indicates potentially higher risk in terms of short-term price fluctuations for SNSE.